Dexcom Inc

Common Name

Dexcom

Country

United States

Sector

Healthcare

Industry

Medical Devices

Employees

10,200

Ticker

DXCM

Exchange

NASDAQ/NGS

Website

www.dexcom.com

Description

Dexcom Inc. is a prominent player in the medical technology sector, specializing in continuous glucose monitoring (CGM) systems for diabetes management. The company's primary function is to develop an... Show more

Financial Statements of Dexcom

Below are the financial statements of Dexcom, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of USD	2024	2023
Current assets	—	—
Cash and cash equivalents	606.1^a	566.3^a
Short-term marketable securities	1,973.3^a	2,157.8^a
Accounts receivable, net	1,005.7^a	973.9^a
Inventory	542.6^a	559.6^a
Prepaid and other current assets	173.7^a	168.3^a
Total current assets	4,301.4^a	4,425.9^a
Assets	—	—
Property and equipment, net	1,339.9^a	1,113.1^a
Operating lease right-of-use assets	62.8^a	71.4^a
Goodwill	22.8^a	25.2^a
Intangibles, net	103.4^a	134.5^a
Deferred tax assets	481.2^a	419.4^a
Other assets	173^a	75^a
Total assets	6,484.5^a	6,264.5^a
Current liabilities	—	—
Accounts payable and accrued liabilities	1,585.1^a	1,345.5^a
Accrued payroll and related expenses	112^a	171^a
Current portion of long-term senior convertible notes	1,204.4^a	0^a
Short-term operating lease liabilities	22.5^a	21.1^a
Deferred revenue	8^a	18.4^a
Total current liabilities	2,932^a	1,556^a
Liabilities and stockholders’ equity	—	—
Long-term senior convertible notes	1,237^a	2,434.2^a
Long-term operating lease liabilities	65^a	80.1^a
Other long-term liabilities	147.9^a	125.6^a
Total liabilities	4,381.9^a	4,195.9^a
Stockholders’ equity	—	—
Preferred stock	0^a	0^a
Common stock	0.4^a	0.4^a
Additional paid-in capital	2,093.8^a	3,514.6^a
Accumulated other comprehensive loss	-8^a	-16.7^a
Retained earnings	1,597.6^a	1,021.4^a
Treasury stock, at cost	-1,581.2^a	-2,451.1^a
Total stockholders’ equity	2,102.6^a	2,068.6^a
Total liabilities and stockholders’ equity	6,484.5^a	6,264.5^a

Verified Sources Behind Dexcom’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Dexcom’s data sources below and access millions more through our Disclosure Search.

a. Dexcom's Annual Report 2024

Trace every data point back to Dexcom’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Dexcom Inc

Financial Statements of Dexcom

Verified Sources Behind Dexcom’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Insulet Corp

Bio Rad Laboratories Inc

Stryker Corp

Procept Biorobotics Corp

Masimo Corp

Penumbra Inc